Her primary scientific interests are in Hepatitis B virus, Virology, cccDNA, Virus and Immunology. Her studies deal with areas such as Hepatitis B, Hepatocellular carcinoma and Intensive care medicine as well as Hepatitis B virus. Her biological study spans a wide range of topics, including Antibody, Monoclonal antibody and Monoclonal.
She combines subjects such as Interferon, Viremia, Adefovir, Viral replication and Minichromosome with her study of cccDNA. Her Virus research is multidisciplinary, incorporating perspectives in Serology and Risk factor. Her research integrates issues of Transplantation and Hepatocyte in her study of Hepadnaviridae.
Her scientific interests lie mostly in Virology, Hepatitis B virus, Immunology, cccDNA and Virus. The various areas that Maura Dandri examines in her Virology study include Immune system and In vivo. Her Hepatitis B virus research integrates issues from Molecular biology and T-cell receptor.
Her work deals with themes such as Adefovir, Hepatocyte, Gene silencing, Minichromosome and Hbeag negative, which intersect with cccDNA. Her research in Virus tackles topics such as Transplantation which are related to areas like Cancer research. Her HBsAg research incorporates elements of Pegylated interferon and Internal medicine.
Maura Dandri focuses on Virology, Hepatitis B virus, cccDNA, Virus and Immune system. Her Virology research includes themes of In vivo, Genotype and Immunotherapy. The Hepatitis B virus study combines topics in areas such as Molecular biology, Hepatitis and T-cell receptor.
Her studies in cccDNA integrate themes in fields like Biological activity, Gene silencing, HBx and APOBEC. Her Virus research includes elements of Viral hepatitis, Antigen processing, Antigen presentation, DNA virus and Innate immune system. Her research investigates the link between Immune system and topics such as Viral replication that cross with problems in Polymerase.
Maura Dandri mainly investigates Hepatitis B virus, cccDNA, Virology, Intensive care medicine and Hepatitis D. Her work on HBsAg is typically connected to p38 mitogen-activated protein kinases as part of general Hepatitis B virus study, connecting several disciplines of science. Her cccDNA research is multidisciplinary, relying on both Biological activity, Cyclin D1 and Immune system.
Her Virology research focuses on Virus in particular. Her studies deal with areas such as Public health, Hepatocellular carcinoma, Hbv reactivation and MEDLINE as well as Intensive care medicine. Her work carried out in the field of Hepatitis D brings together such families of science as Antigen, Liver regeneration, Coinfection, HBcAg and Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
Julie Lucifora;Yuchen Xia;Florian Reisinger;Ke Zhang.
Control of cccDNA function in hepatitis B virus infection
Massimo Levrero;Teresa Pollicino;Jorg Petersen;Laura Belloni.
Journal of Hepatology (2009)
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B
Karsten Wursthorn;Marc Lutgehetmann;Maura Dandri;Tassilo Volz.
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
Laura Belloni;Lena Allweiss;Francesca Guerrieri;Natalia Pediconi.
Journal of Clinical Investigation (2012)
Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus
Maura Dandri;Martin R. Burda;Eva Török;Joerg M. Pollok.
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.
Joerg Petersen;Maura Dandri;Walter Mier;Marc Lütgehetmann.
Nature Biotechnology (2008)
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
Tassilo Volz;Lena Allweiss;Mounira Ben MBarek;Michael Warlich.
Journal of Hepatology (2013)
New insight in the pathobiology of hepatitis B virus infection
Maura Dandri;Stephen Locarnini.
Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients.
Tassilo Volz;Marc Lutgehetmann;Paul Wachtler;Anna Jacob.
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Marc Lütgehetmann;Lida V. Mancke;Tassilo Volz;Martina Helbig.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: